Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Idiopathic Pulmonary Fibrosis Clinical Trials

105 recruiting trials for Idiopathic Pulmonary Fibrosis. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
105
Total Trials
105
Recruiting Now
8
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGNCT00001532

Role of Genetic Factors in the Development of Lung Disease

This study is designed to evaluate the genetics involved in the development of lung disease by surveying genes involved in the process of breathing and examining the genes in lung...

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)Enrolling: 35002 locations
RECRUITINGPhase 1 / Phase 2NCT07464132

Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases

The purpose of this study is to conduct clinical research on \[68Ga\] Ga-NI-FAPI-04 PET/CT imaging and further investigate its diagnostic value in fibroblast activation related...

Sponsor: Peking Union Medical College HospitalEnrolling: 301 location
RECRUITINGPhase 2NCT06325696

H01 in Adults With Interstitial Lung Disease (The SOLIS Study)

Background: Interstitial lung disease affects the tissues that aid the transfer of oxygen and carbon dioxide between the air and the bloodstream. The disease can cause fibrosis,...

Sponsor: National Institute of Environmental Health Sciences (NIEHS)Enrolling: 371 location
RECRUITINGEarly Phase 1NCT06163482

Hormonal Responses to a Mixed Meal in People With Cystic Fibrosis

In this exploratory study, the hormonal responses to a mixed meal will be examined in people with cystic fibrosis. The aim of this study is to find correlates with impaired...

Sponsor: University of CincinnatiEnrolling: 611 location
RECRUITINGNCT05359991

Exercise in Child Health

This study is a cooperative investigation funded by the NIH. The project is a collaboration among three major NIH Clinical Translational Science Awardees: 1) UCI (lead site with...

Sponsor: University of California, IrvineEnrolling: 2401 location
RECRUITINGNCT04002882

Role of Body Fat Distribution in Metabolic and Pulmonary Decline in Cystic Fibrosis (ORBIT-CF)

Nutrition and body composition, the amount of muscle and fat in the body, has a role in overall health. This study wants to learn more about how nutrition and body composition...

Sponsor: Emory UniversityEnrolling: 902 locations
RECRUITINGNCT01851642

Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs

The purpose of this study is to look at how Alpha-1-antitrypsin (AAT) deficiency and Cystic Fibrosis (CF) affect white blood cells in the lungs, called macrophages, and their...

Sponsor: University of FloridaEnrolling: 2201 location
RECRUITINGNCT07135869

Muscle Fatigue in People With Cystic Fibrosis: Insight From a Mobile App

Muscle fitness is an important component of health. For instance, the ability to resist to muscle fatigue development is important for daily functioning. Previous studies have...

Sponsor: Universidad Católica San Antonio de MurciaEnrolling: 681 location
RECRUITINGPhase 2 / Phase 3NCT06125327

SC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)

Evaluating Sufenidone (SC1011) in IPF patients for efficacy and safety. Includes screening, treatment, and follow-up, with FVC decline and health checks.

Sponsor: Guangzhou JOYO Pharma Co., LtdEnrolling: 2101 location
RECRUITINGNCT06251622

Muscle Function and Physical Activity in the Modern Era of Cystic Fibrosis

Cystic fibrosis (CF) is characterized by various extrapulmonary manifestations, including altered skeletal muscle function, with both quantitative (e.g. reduced muscle mass) and...

Sponsor: Hospices Civils de LyonEnrolling: 1121 location
RECRUITINGNCT07070362

Digital Early Warning System for Acute Lung Injury in Liver Surgery

This study focuses on developing an explainable machine learning model based on cardiopulmonary interaction characteristics to achieve early prediction of acute lung injury (ALI)...

Sponsor: Beijing Tsinghua Chang Gung HospitalEnrolling: 40001 location
RECRUITINGNCT05635266

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

To collect, preserve, and/or distribute annotated biospecimens and associated medical data to institutionally approved, investigator-directed biomedical research to discover and...

Sponsor: Sanguine BiosciencesEnrolling: 200001 location
RECRUITINGPhase 3NCT05422222

Evaluation of VX-121/Tezacaftor/Deutivacaftor in Cystic Fibrosis (CF) Participants 1 Through 11 Years of Age

The purpose of this study is to evaluate the pharmacokinetics, safety, tolerability and efficacy of VX-121/tezacaftor/deutivacaftor (VX-121/TEZ/D-IVA) in CF participants with at...

Sponsor: Vertex Pharmaceuticals IncorporatedEnrolling: 21020 locations
RECRUITINGNCT06950892

Remote Sputum Collection in Cystic Fibrosis

Elexacaftor/Tezacaftor/Ivacaftor or Trikafta improves lung health in people with cystic fibrosis (CF), including decreased cough and mucous production. Diagnosing lung infections...

Sponsor: University of PennsylvaniaEnrolling: 1503 locations
RECRUITINGPhase 2NCT07192939

Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Trial to Evaluate the Efficacy and Safety of...

To evaluate the efficacy and safety of HRS-9813 in subjects with pulmonary fibrosis。

Sponsor: Guangdong Hengrui Pharmaceutical Co., LtdEnrolling: 2701 location
RECRUITINGEarly Phase 1NCT03587961

Personalized Theratyping Trial

The purpose of this study is to explore the use of off-label CFTR modulators that may affect CFTR function in patients with CFTR mutations that are not currently approved for...

Sponsor: George SolomonEnrolling: 201 location
RECRUITINGPhase 2NCT06532071

Advanced Imaging for Pulmonary Fibrosis

The purpose of this study is to determine if measurements of active collagen deposition using \[68Ga\]CBP8 positron emission tomography (PET) and tissue injury using dynamic...

Sponsor: Peter CaravanEnrolling: 601 location
RECRUITINGNCT06066723

19F MRI in Healthy Children and Children With Mild Cystic Fibrosis Lung Disease

This study capitalizes on the emerging technology of 19F MRI, using conventional 'thermally' polarized perfluorinated gas (perfluoropropane, or PFP) mixed with oxygen and studied...

Sponsor: University of North Carolina, Chapel HillEnrolling: 151 location
RECRUITINGNCT06191640

Sinus Disease in Young Children With Cystic Fibrosis

This is a prospective, observational study examining the impact of highly effective cystic fibrosis transmembrane conductance regulator (CFTR) modulators on chronic rhinosinusitis...

Sponsor: University of California, Los AngelesEnrolling: 806 locations
RECRUITINGNCT06069115

Radiotherapy Exposed Lung Injury: Effect on Functioning - Cohort

Prospective cohort research to study the state of oxygen metabolism, reserve capabilities of cardiovascular and respiratory systems in patients with breast cancer to create a...

Sponsor: Meshalkin Research Institute of Pathology of CirculationEnrolling: 2001 location
RECRUITINGNCT06732674

Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases

The RMD-mILDer trial is a home monitoring strategy trial aiming to improve management of interstitial lung disease related to rheumatic diseases applying eHealth technology. It...

Sponsor: Oslo University HospitalEnrolling: 2181 location
RECRUITINGPhase 2NCT06736990

A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis

The goal of this clinical trial is to learn if the investigational drug CAL101 can help prevent further decline in lung function in adults with Idiopathic Pulmonary Fibrosis....

Sponsor: Calluna Pharma ASEnrolling: 15020 locations
RECRUITINGEarly Phase 1NCT06267183

A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of SV001 in Chinese Healthy Adult Volunteers.

The purpose of this study is to evaluate safety, tolerability, PK and immunogenicity of SV001 compare to placebo in Chinese healthy adult volunteers.

Sponsor: Shanghai Synvida Biotechnology Co.,Ltd.Enrolling: 531 location
RECRUITINGNCT06323876

The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis

This observational study involves obtaining 2 chest CT scans; a historical baseline CT within ±1 year of enrollment into PRECISIONS, and a follow-up CT (either historical or...

Sponsor: University of VirginiaEnrolling: 1601 location
RECRUITINGNCT06264934

An Investigation Into Dielectric Assessment of Permittivity and Conductivity in Human Using a Novel Electrical...

The goal of this observational study is to investigate the ability of a the Z-scanner to identify and differentiate cancer and benign lesions from healthy breast tissue based on...

Sponsor: Zedsen LimitedEnrolling: 901 location
RECRUITINGNCT06644144

P4O2 ILD Extension

The goal of this observational study is to identify early biomarkers that can predict the development of progressive pulmonary fibrosis (PPF) in participants with interstitial...

Sponsor: Amsterdam UMC, location VUmcEnrolling: 4501 location
RECRUITINGNCT07303621

Population Pharmacokinetics of Elexacaftor-tezacaftor-ivacaftor in a Paediatric Population

Cystic fibrosis is a rare, progressive genetic disease caused by a mutation in the CFTR (cystic fibrosis transmembrane conductance regulator) gene. Respiratory and nutritional...

Sponsor: Hospices Civils de LyonEnrolling: 1501 location
RECRUITINGPhase 1NCT07407543

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SRN001 in Healthy Korean and...

To evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of SRN001 in healthy adult volunteers.

Sponsor: siRNAgen Therapeutics Inc.Enrolling: 301 location
RECRUITINGPhase 2NCT06951217

An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

This is an open-label extension study for participants who were previously enrolled in and completed an Avalyn Pharma Sponsored study with an inhaled antifibrotic, such as AP01....

Sponsor: Avalyn Pharma Inc.Enrolling: 34020 locations
RECRUITINGNCT05279040

Trikafta Exercise Study in Cystic Fibrosis

Shortness of breath (dyspnea) during exercise is a major source of distress and is a commonly reported symptom in patients with cystic fibrosis (CF). A recent drug treatment...

Sponsor: University of British ColumbiaEnrolling: 201 location
RECRUITINGNCT05200429

Canadian Observational Study Evaluating the Long-term IMPACT of Cystic Fibrosis Transmembrane Conductance Regulator...

This observational study intends to investigate health trends and data in cystic fibrosis patients all across Canada that are receiving modulator treatment so researchers can...

Sponsor: University of British ColumbiaEnrolling: 5002 locations
RECRUITINGPhase 3NCT07299695

Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis

Acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF) are sudden and severe worsening episodes that can be life-threatening. Currently, no treatment has been proven to...

Sponsor: Argyrios TzouvelekisEnrolling: 1961 location
RECRUITINGNCT07486206

Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 Trial

The OPTIMIZE-ILD-2 trial is a prospective, randomized, open-label clinical trial designed to evaluate the impact of a coordinated follow-up pathway on patients with established...

Sponsor: Hospital de GranollersEnrolling: 1521 location
RECRUITINGNCT06273566

French Validation of the AdT-Physio Scale

The goal of this observational study is to translate and validate the Adt-Physio scale in French, and to validate on a large number of patients the French translation of the...

Sponsor: Pole Sante Grace de DieuEnrolling: 1211 location
RECRUITINGPhase 3NCT06238622

A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a...

This study is open to people with idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF). They can only take part if they have completed treatment in a...

Sponsor: Boehringer IngelheimEnrolling: 170020 locations
RECRUITINGNCT06917196

PROOF OF CONCEPT STUDY ON THE EFFICACY OF INHALATORY TARGETED IMATINIB NANOFORMULATIONS IN PULMONARY HYPERTENSION AND...

The PROMPTLY study is a proof-of-concept research project evaluating the efficacy of XHALIP, an innovative inhalable formulation of Imatinib, in treating pulmonary arterial...

Sponsor: Fondazione IRCCS Policlinico San Matteo di PaviaEnrolling: 161 location
RECRUITINGPhase 2NCT06747923

SB17170 Phase 2 Trial in IPF Patients

This clinical trial is a 2:2:1 randomized, double-blind, placebo-controlled, parallel group, exploratory phase II trial. The main objective of this trial is to compare and...

Sponsor: SPARK BiopharmaEnrolling: 305 locations
RECRUITINGPhase 1NCT05016817

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IPF

This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of Idiopathic...

Sponsor: The Foundation for Orthopaedics and Regenerative MedicineEnrolling: 201 location
RECRUITINGPhase 2NCT07002034

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

The purpose of this study is to determine if treatment with a single dose of RE104 for Injection reduces depressive symptoms or depressive symptoms mixed with anxiety symptoms in...

Sponsor: Reunion Neuroscience IncEnrolling: 10020 locations
RECRUITINGNCT05604495

Screening for Cystic Fibrosis and Cystic Fibrosis Related Disorders in Chinese Adults With Bronchiectasis

The study carries out Sweet Tests and CFTR-mutation screening to explore the prevalence, clinical characteristics, and prognosis of cystic fibrosis, as well as the CFTR-mutation...

Sponsor: Shanghai Pulmonary Hospital, Shanghai, ChinaEnrolling: 10001 location
RECRUITINGNCT07289100

Novel Sensors and Artificial Intelligence for Detection of Acute Pulmonary Exacerbations in Cystic Fibrosis and...

The goal of this observational study is to learn about new sensors that measure changes in the body that happen during a chest infection, such as breathing rate and heart rate....

Sponsor: Papworth Hospital NHS Foundation TrustEnrolling: 501 location
RECRUITINGNCT07508904

Exercises' Effect on Muscle Strength, Aerobic Capacity and Respiratory Functions in Cystic Fibrosis

This research aims to evaluate the effects of upper and lower limb exercises on muscle strength and pulmonary function in children diagnosed with CF. While aerobic training is a...

Sponsor: Riphah International UniversityEnrolling: 221 location
RECRUITINGNCT06797206

A Study of Females With CF Throughout Pregnancy and Post-partum, and Follow up of Their Offspring

In this study, investigators aim to study in detail the physical (including nutritional and pulmonary) and mental health of females with cystic fibrosis (CF) planning a pregnancy,...

Sponsor: Royal Brompton & Harefield NHS Foundation TrustEnrolling: 601 location
RECRUITINGPhase 2NCT02740868

Xenon-129 and Inert Fluorinated Gas Lung MRI: Study of Healthy Volunteers and Participants With Pulmonary Disease

Aim of this study is to evaluate image quality and reproducibility of Xenon-129 and Inert fluorinated (19F) gas Magnetic Resonance Imaging (MRI) and to evaluate changes in lung...

Sponsor: The Hospital for Sick ChildrenEnrolling: 301 location
RECRUITINGNCT01915511

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

The Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry started recruiting in 2014 with the objective of studying Idiopathic Pulmonary Fibrosis. In 2018, the...

Sponsor: Duke UniversityEnrolling: 300020 locations
RECRUITINGPhase 4NCT05548283

Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study

The purpose of this study is to look at pulmonary exacerbations in people with cystic fibrosis (CF) that need to be treated with antibiotics given through a tube inserted into a...

Sponsor: Chris GossEnrolling: 73020 locations
RECRUITINGPhase 3NCT05075161

Pirfenidone to Prevent Fibrosis in Ards.

Acute respiratory distress syndrome (ARDS) is a severe form of acute lung injury and a major cause of Intensive Care Unit (ICU) admission worldwide. Despite a large number of...

Sponsor: Università Vita-Salute San RaffaeleEnrolling: 13017 locations
RECRUITINGPhase 2NCT07333183

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

This is a Phase 2, open-label, multi-center clinical study to evaluate the safety and efficacy of inhaled mosliciguat in participants with pulmonary hypertension associated with...

Sponsor: Pulmovant, Inc.Enrolling: 201 location
RECRUITINGPhase 3NCT05677971

Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring...

The main aim of this study is to learn if fazirsiran reduces liver scarring (fibrosis) compared to placebo. Other aims are to learn if fazirsiran slows down the disease worsening...

Sponsor: TakedaEnrolling: 16020 locations
RECRUITINGNCT06595420

Kidney Function in People With Cystic Fibrosis in the Era of HEMT

The purpose of this study is to find out what causes kidney disease in people with CF. The investigators will study biomarkers in the blood and urine that can either predict who...

Sponsor: University of VirginiaEnrolling: 2603 locations

Showing 50 of 105 trials.Search all Idiopathic Pulmonary Fibrosis trials